Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model - Wikidata - awgldk - TriplyDB

Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model

Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model

http://www.wikidata.org/entity/Q28293140

about

A Genetic-Pathophysiological Framework for Craniosynostosis Talocalcaneal coalition in Muenke syndrome: report of a patient, review of the literature in FGFR-related craniosynostoses, and consideration of mechanism Functional diversity of fibroblast growth factors in bone formation Mesodermal Tbx1 is required for patterning the proximal mandible in mice FGFR1 signaling is associated with the magnitude of morphological integration in human head shape.Genetic rescue of Muenke syndrome model hearing loss reveals prolonged FGF-dependent plasticity in cochlear supporting cell fates.Ectodermal Wnt/β-catenin signaling shapes the mouse face.Impact of genetics on the diagnosis and clinical management of syndromic craniosynostoses.A deletion of FGFR2 creating a chimeric IIIb/IIIc exon in a child with Apert syndrome The Fibroblast Growth Factor signaling pathway Palatal and oral manifestations of Muenke syndrome (FGFR3-related craniosynostosis).Prevention of premature fusion of calvarial suture in GLI-Kruppel family member 3 (Gli3)-deficient mice by removing one allele of Runt-related transcription factor 2 (Runx2).Gain-of-Function Mutations in ZIC1 Are Associated with Coronal Craniosynostosis and Learning Disability.Contribution of FGFR1 Variants to Craniofacial Variations in East Asians From shape to cells: mouse models reveal mechanisms altering palate development in Apert syndrome Fibroblast growth factor 10 plays a causative role in the tracheal cartilage defects in a mouse model of Apert syndrome.Fgf10-expressing tanycytes add new neurons to the appetite/energy-balance regulating centers of the postnatal and adult hypothalamus.BCL11B regulates sutural patency in the mouse craniofacial skeleton.Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model.Smad7 modulates TGFβ signaling during cranial suture development to maintain suture patency.Mouse models of Apert syndrome.Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes Research advances in Apert syndrome

P2860

Q26784240-E0E49658-056A-437D-A342-6A9C244509A2 Q26860951-6F160FC8-1AB4-43CA-A21B-D39EF68271DC Q28086929-367C39F8-5289-4B4F-AD31-57282819F8F2 Q28592838-AF53FBAD-9707-4D3C-9E72-720D7FB32642 Q30356627-8DB8D3B1-CCB2-46FA-842D-313DF9BDB7DB Q30439081-5917762C-D71D-4A74-9129-EF6668B47A5F Q30498676-84707C51-3D7B-4271-BC69-BE08642B06F7 Q33911968-02B0C66A-D6D8-4D30-966E-591A3922DD8F Q34029106-C2994DDC-34C2-45A5-9B1A-843A928E52D6 Q34467171-0994F84D-04E3-4C53-A163-46414326B865 Q35992146-30D3A552-897E-4C83-8B13-443CE9B0D675 Q36033280-3471D816-D23F-456B-8892-3F754C32234A Q36044883-56B133AF-E8E9-48FD-9272-A8E3AF707ADE Q36262722-B9DAB8E6-9EE5-4EDD-9642-9987E62AAF08 Q36790968-03C09AB4-8F1A-4F60-9F31-8E9AD3933B2E Q37050141-FDB51324-C4B4-4FF0-A229-685C9485B78A Q37077300-6858BBF4-A630-42B7-B5E4-A063C156C843 Q40006898-DD71E100-B49D-44C9-A542-2C2B4C6F1522 Q45345173-612A9441-2C49-45FC-B9BB-DB7F4A1C8EDA Q47743466-559BEEB9-4238-4582-B9BF-6FCE55AB2BBC Q48416696-268DFB0B-FF2A-44AD-AFA2-DC56A4331A25 Q56329626-51487EC7-7F2D-4C43-A8A6-CFE332321E09 Q57920914-C54F39F9-2743-42A4-AEDE-E705BF1AF3A6

P2860

Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model

http://www.wikidata.org/entity/Q28293140

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@ast

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@en

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@nl

type

label

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@ast

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@en

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@nl

prefLabel

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@ast

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@en

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@nl

P1433

Q28293140-FD3734C0-2E41-482D-B690-2B078D80562C

P1476

Q28293140-58AE4409-5253-4057-9B3B-76AD62A3EA10

P2093

Q28293140-2F8ACC1D-42F1-47FA-A108-057640E2B666

Q28293140-622196D6-1B47-40A3-8B84-739FBA88B8BE

Q28293140-71E69992-EB47-4092-A470-DAF63A477D00

Q28293140-90A74E47-DDE2-40F8-B081-27504903D810

Q28293140-BD49E291-623A-4255-BFB2-BD7EFA2DB011

Q28293140-D7088BE2-C726-4AF9-9392-47C49A2025C7

Q28293140-DA7D3DE6-D659-4025-82D0-43DB17240826

P2860

Q28293140-096CFF83-749C-4601-85EF-D65156101DE8

Q28293140-0B92F688-49E4-4BC3-A84C-2FF9BBF34199

Q28293140-1B2415B9-7F27-4DBC-8673-B4894E1FE747

Q28293140-22684C89-256D-4373-BBEE-4D5E2C86A6F2

Q28293140-3F83815B-A863-4A01-B331-B0128DBC2F4D

Q28293140-406EFA9E-35B6-4FC1-896E-D33AECA4CA13

Q28293140-45BA3F01-1FC6-4EF7-883F-16CCE8450E27

Q28293140-4E8F32BA-9524-4906-993C-D5B9D0405BE7

Q28293140-52379528-9D7C-49FD-9E4F-F5415503A6C0

Q28293140-5B29D474-4AA6-4815-ABCD-1051B166B29E

P304

Q28293140-DE0745B8-CC8B-4F8D-A910-8603F0B998F2

P31

Q28293140-12741488-F9E3-4231-8CC3-23CDE76070D7

P356

Q28293140-0B862B60-DFE2-40AF-952B-0DF8872A6274

P407

Q28293140-4D1ED922-0717-4A9D-B5D7-294A8329AD94

P433

Q28293140-CAD59BA8-B32E-4794-91D0-08AACED754F6

P478

Q28293140-DC97F441-44DC-4F02-9186-8905FF05D1BD

P50

Q28293140-65390DBA-5003-4488-998A-B8C5669F11E7

P577

Q28293140-4329F887-037F-46D9-BAD6-4C89457D758B

P5875

Q28293140-45CD576D-6CE4-43CB-8608-CDF98C6B2DC5

P698

Q28293140-154B8C39-00CC-46ED-93EA-14E9F962C351

P356

P1433

Developmental Dynamics

P1476

Evidence that Fgf10 contribute ...... an Apert syndrome mouse model

@en

P2093

Anne Donjacour

http://www.w3.org/2001/XMLSchema#string

Clive Dickson

http://www.w3.org/2001/XMLSchema#string

David P Rice

http://www.w3.org/2001/XMLSchema#string

Eva Lana-Elola

http://www.w3.org/2001/XMLSchema#string

Jean Pegrum

http://www.w3.org/2001/XMLSchema#string

Mohammad K Hajihosseini

http://www.w3.org/2001/XMLSchema#string

Raquel Duarte

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for FGF receptor dimerization and activation

Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis

Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations

Functional evolutionary history of the mouse Fgf gene family

Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2)

Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus

Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands

Promotion and attenuation of FGF signaling through the Ras-MAPK pathway

P304

376-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DVDY.21648

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

238

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229560850

http://www.w3.org/2001/XMLSchema#string

P698

18773495

http://www.w3.org/2001/XMLSchema#string